STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
ODT ODONATE THERAPEUTICS INCORPORATED StockScouter® Report
4
StockScouter® Score
ODONATE THERAPEUTICS INCORPORATED, a micro cap company in the healthcare sector, is expected to slightly underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated rapidly compared to earnings growth in the past three years. Positive
- Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a small company like ODT
Concerns
- Two or more executives, directors or major shareholders sold a large number of shares recently. Very negative
- Moving average analysis for ODT suggests weak price movement over the medium term. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be out of favor, stocks will be , and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
B
F
N/A
C